Gw. Oliver et al., QUANTITATIVE REVERSE ZYMOGRAPHY - ANALYSIS OF PICOGRAM AMOUNTS OF METALLOPROTEINASE INHIBITORS USING GELATINASE-A AND GELATINASE-B REVERSE ZYMOGRAMS, Analytical biochemistry, 244(1), 1997, pp. 161-166
Matrix metalloproteinases are a growing family of neutral pH optima, z
inc atom-dependent endopeptidases that collectively degrade all compon
ents of the extracellular matrix. This family of related proteases is
further defined by their inhibition of protease activity by a class of
low-molecular-weight endogenous inhibitors known as tissue inhibitors
of metalloproteinases or TIMPs, Reverse zymography is an electrophore
tic technique used to identify TIMP inhibitory activity within acrylam
ide gels. Previous methods have generally used biochemically complex s
ources of proteolytic activity (such as cell culture conditioned media
) copolymerized with a proteinase substrate in the gel to identify the
zones of inhibited proteolysis. We describe a novel system for revers
e zymography using purified recombinant human gelatinase A or gelatina
se B in place of conditioned media. These reverse zymograms using reco
mbinant gelatinase have sensitivities for TIMPs that are favorable in
comparison to immunoblotting techniques but have the benefit of visual
izing multiple inhibitors simultaneously. We have developed and charac
terized these methods for the evaluation of inhibitors and have shown
them to be highly sensitive, convenient, and reproducible. Both system
s detect TIMPs 1, 2, and 3 simultaneously, but with differential sensi
tivities for TIMPs 1 and 2. Using gelatinase A the system can detect a
s little as 1 pg of rTIMP-8, but the limit of detection for rTIMP-1 is
40 pg. Gelatinase B shows less differential activity in that the limi
ts of detection are 60 and 40 pg for TIMP-2 and TIMP-1, respectively.
We demonstrate how these varied sensitivities of the gelatinases for t
he TIMPs can contribute to potential pitfalls in systems using unchara
cterized reagents (i.e., conditioned media). (C) 1997 Academic Press,
Inc.